Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the most critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers an... Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the most critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers and autoimmune diseases. The company's lead product candidate is CPI-006 which is a potent humanized monoclonal antibody that is designed to react with a specific site on CD73. Its other product candidates are CPI-818, CPI-935, CPI-182 and Ciforadenant. Show more
Soquelitinib is a potential first-in-class ITK inhibitor with broad potential in cancer and immune diseases There are currently no fully approved agents for the treatment of relapsed PTCL and...
BURLINGAME, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc.Β (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that Richard A. Miller, M.D...
Early Results from Soquelitinib Phase 1 Randomized Trial in Atopic Dermatitis Demonstrate Clinical Activity and Corresponding Changes in Cytokine Levels Consistent with ITK Inhibition Mechanism of...
Soquelitinib registrational Phase 3 clinical trial in PTCL advancing toward initial enrollment in Q3 2024 Fast track designation underscores unmet need for patients with relapsed or refractory...
BURLINGAME, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc.Β (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a...
Data demonstrated in vitro and in vivo ITK inhibition with soquelitinib induced switching of proinflammatory Th17 cells into anti-inflammatory Treg cells Publication confirms and extends...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.18 | 25.7641921397 | 4.58 | 6.15 | 4.58 | 874500 | 5.45901733 | CS |
4 | 1.63 | 39.4673123487 | 4.13 | 6.15 | 3.87 | 477942 | 4.84571245 | CS |
12 | 3.76 | 188 | 2 | 6.15 | 1.75 | 362592 | 3.91578781 | CS |
26 | 3.84 | 200 | 1.92 | 6.15 | 1.3 | 290763 | 3.03129805 | CS |
52 | 4.19 | 266.878980892 | 1.57 | 6.15 | 1.05 | 248373 | 2.51497056 | CS |
156 | 0.79 | 15.8953722334 | 4.97 | 9.54 | 0.607 | 685396 | 4.65175043 | CS |
260 | 2.316 | 67.2473867596 | 3.444 | 9.54 | 0.607 | 854445 | 4.68028213 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.